| |
 |
|
Class Information
Number: 514/177
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein a nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen atom through a double bond (C=O).
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6369115 |
Stabilized powder formulations |
Apr. 9, 2002 |
| 6365580 |
Process for the production of difluoromethane |
Apr. 2, 2002 |
| 6352980 |
Estrenes for inducting hypothalamic effects |
Mar. 5, 2002 |
| 6331534 |
Steroids as neurochemical stimulators of the VNO to alleviate pain |
Dec. 18, 2001 |
| 6319901 |
Methods for prolonging cell membrane permeability |
Nov. 20, 2001 |
| 6316431 |
Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
Nov. 13, 2001 |
| 6306914 |
Progestin therapy for maintaining amenorrhea |
Oct. 23, 2001 |
| 6297228 |
Use of angiostatic steroids in photodynamic therapy |
Oct. 2, 2001 |
| 6277829 |
Process for preparing of aqueous formulation for opthalmic use |
Aug. 21, 2001 |
| 6274572 |
Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
Aug. 14, 2001 |
| 6271220 |
Anti-angiogenic agents |
Aug. 7, 2001 |
| 6262042 |
17.beta.-amino and hydroxylamino-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
Jul. 17, 2001 |
| 6245757 |
Use of progestins to treat ischemic event |
Jun. 12, 2001 |
| 6242436 |
Use of 5alpha-androstanediol or 5alpha-androstanedione to increase dihydrotestosterone levels in humans |
Jun. 5, 2001 |
| 6228850 |
Antiangiogenic activity of betulinic acid and its derivatives |
May. 8, 2001 |
| 6221377 |
Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
Apr. 24, 2001 |
| 6218435 |
Reduction of hair growth |
Apr. 17, 2001 |
| 6187750 |
Method of hormone treatment for patients with symptoms consistent with multiple sclerosis |
Feb. 13, 2001 |
| 6180682 |
Buccal drug delivery system for use in male contraception |
Jan. 30, 2001 |
| 6177418 |
Tetracyclic triterpenes as cholesterol-lowering and anti-atherosclerosis agents |
Jan. 23, 2001 |
| 6172052 |
17.beta.-acyl-17.alpha.-propynyl-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
Jan. 9, 2001 |
| 6153606 |
Memory enhancement by the administration of .DELTA.5-androstene-3.beta.-ol-7,17-dione and 3.beta. esters thereof |
Nov. 28, 2000 |
| 6153607 |
Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance (or turnover) |
Nov. 28, 2000 |
| 6150348 |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
Nov. 21, 2000 |
| 6147066 |
Use of antimineralocorticoid compounds against drug withdrawal syndrome |
Nov. 14, 2000 |
| 6147065 |
14-.alpha., 17-.alpha.-C.sub.2 bridged norprogesterone derivatives |
Nov. 14, 2000 |
| 6143737 |
Progesterone analogs to reverse multidrug resistance |
Nov. 7, 2000 |
| 6143736 |
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
Nov. 7, 2000 |
| 6140315 |
Therapeutic uses of goserelin acetate |
Oct. 31, 2000 |
| 6140316 |
Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions |
Oct. 31, 2000 |
| 6117860 |
Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia |
Sep. 12, 2000 |
| 6113949 |
Weight control product and method of treating hyperlipidemia and increasing vigor with said product |
Sep. 5, 2000 |
| 6114319 |
Compositions containing difluprednate |
Sep. 5, 2000 |
| 6107276 |
Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent |
Aug. 22, 2000 |
| 6103710 |
Glucocorticoid response elements |
Aug. 15, 2000 |
| 6096731 |
Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation |
Aug. 1, 2000 |
| 6096733 |
Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
Aug. 1, 2000 |
| 6093389 |
Methods and compositions for attracting and controlling termites |
Jul. 25, 2000 |
| 6083941 |
Inhibition of NMDA receptor activity by pregnenolone sulfate derivatives |
Jul. 4, 2000 |
| 6083940 |
Method and composition for effecting contraception in a mammalian male |
Jul. 4, 2000 |
| 6077531 |
Estradiol and progesterone-based medicament |
Jun. 20, 2000 |
| 6066627 |
Steroids as neurochemical initiators of change in human blood levels of LH |
May. 23, 2000 |
| 6063402 |
Purified galactomannan as an improved pharmaceutical excipient |
May. 16, 2000 |
| 6056972 |
Method for reducing coronary artery reactivity |
May. 2, 2000 |
| 6054447 |
Progesterone for treating or reducing ischemia |
Apr. 25, 2000 |
| 6048848 |
Use of pregnane-diones as analgesic agents |
Apr. 11, 2000 |
| 6046184 |
Medicament for treating obesity and improving lipid metabolism |
Apr. 4, 2000 |
| 6046182 |
Steroid carbamates as potentiating agents |
Apr. 4, 2000 |
| 6028064 |
Prevention of ovarian cancer by administration of progestin products |
Feb. 22, 2000 |
| 6028106 |
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents |
Feb. 22, 2000 |
|
|
|
